Medicare overpayments could cost Amedisys upwards of $38.8M

    By
    -

    Baton Rouge-based Amedisys is facing a potential loss ranging from $6.5 million to $38.8 million due to alleged Medicare overpayments in Florida, the company announced today in SEC filings. Palmet…


    Already an INSIDER? Sign in.